# Ysios Capital: portfolio, investments and team

> Ysios Capital is a vc firm based in Spain. 35 investments on record, 2 in the last 12 months, latest Sept 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/ysios-capital (Millionrounds; every figure on the page links to its filing or article)

Spain · [Investor](https://millionrounds.com/investors)

# Ysios Capital

Last cheque observed Sep 2026; 35 cheques on record.

Email

Deploying now VC firm

Seed Series A Series B Banking Funding Platform Venture Capital & Private Equity

Follow Ysios Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fysios-capital)

Deploying now

**100%** of best year **2** **cheques in 12 months**, 35 on record

Since the last cheque **38** days **00** hrs **00** min **00** sec

Median round **$33M** Cheque size, as they say **$1.0M – $7.5M** Rounds led **0 of 35** Sole investor **3 rounds** Exits **2 from the portfolio** Mostly in **Spain, 45%**

Pitch Ysios Capital

## Ysios Capital highlights

- 01 2 cheques in the last 12 months
- 02 Mostly Series B and Series A: 63% of its rounds
- 03 Sole investor in 3 rounds, median $2.8M
- 04 2 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** $1.0M – $7.5M as they say
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Banking Funding Platform Venture Capital & Private Equity
- **Based in:** San Sebastian, Spain
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **35 appearances**

- **2026** 2 rounds
- **Sept** **[Anaconda Biomed](https://millionrounds.com/company/anaconda-biomed)** Series C · ES · Asabys **$56M** With 5 others
- **Jun** **[Ona Therapeutics](https://millionrounds.com/company/ona-therapeutics)** Series B · ES · Asabys **$87M** With 11 others
- **2019** 2 rounds
- **Dec** **[Anaconda](https://millionrounds.com/company/anaconda)** Series B · ES · FinSMEs **$22M** With 4 others
- **Jul** **[AM-Pharma](https://millionrounds.com/company/am-pharma)** NL · FinSMEs **$130M** With 7 others
- **2018** 3 rounds
- **Oct** **[Galecto](https://millionrounds.com/company/galecto)** Series C · DK · FinSMEs **$90M** With 9 others
- **Sept** **[Minoryx](https://millionrounds.com/company/minoryx)** Series B · ES · FinSMEs **$25M** With 9 others
- **May** **[BioClin](https://millionrounds.com/company/bioclin)** Series B · FinSMEs **$20M** With 6 others
- **2017** 5 rounds
- **Dec** **[Aura Biosciences](https://millionrounds.com/company/aura-biosciences)** Series C · US · 4-traders **$30M** With 9 others
- **Nov** **[Xeltis](https://millionrounds.com/company/xeltis)** Series C · CH · FinSMEs **$53M** Sole investor
- **May** **[Anaconda Biomed](https://millionrounds.com/company/anaconda-biomed)** Series A · ES · FinSMEs **$17M** With 3 others
- **Mar** **[MedLumics](https://millionrounds.com/company/medlumics)** Series B · ES · FinSMEs **$37M** With 2 others
- **Feb** **[Prexton Therapeutics](https://millionrounds.com/company/prexton-therapeutics)** Series B · CH · FinSMEs **$31M** With 4 others
- **2016** 2 rounds
- **Nov** **[OxThera](https://millionrounds.com/company/oxthera)** SE · FinSMEs **$34M** With 3 others
- **Sept** **[Aura Biosciences](https://millionrounds.com/company/aura-biosciences)** US · FinSMEs **$8.0M** With 2 others
- **2015** 4 rounds
- **Oct** **[Minoryx Therapeutics](https://millionrounds.com/company/minoryx-therapeutics)** Series A · ES **$22M** With 6 others
- **Sept** **[SANIFIT](https://millionrounds.com/company/sanifit)** Series C · ES **$41M** With 6 others
- **Mar** **[Aura Biosciences](https://millionrounds.com/company/aura-biosciences)** Series B · US **$21M** With 4 others
- **Feb** **[Prexton Therapeutics](https://millionrounds.com/company/prexton-therapeutics)** Series A · CH **$10M** With 2 others
- **2014** 2 rounds
- **Sept** **[AM Pharma](https://millionrounds.com/company/am-pharma)** Series E · NL **$16M** With 5 others
- **Apr** **[Kala Pharmaceuticals](https://millionrounds.com/company/kala-pharmaceuticals)** Series B · US **$23M** With 5 others
- **2013** 3 rounds
- **Dec** **[Acousticeye](https://millionrounds.com/company/acousticeye)** Venture · NL · finsmes.com **$7.0M** With 3 others
- **Oct** **[CVRx](https://millionrounds.com/company/cvrx)** Series F · US · finsmes.com **$12M** With 1 other
- **Oct** Series A · sec.gov **$2.7M** With 10 others
- **2012** 2 rounds
- **Nov** **[Endosense](https://millionrounds.com/company/endosense)** Series C · CH · finsmes.com **$40M** With 7 others
- **Jun** **[Inbiomotion](https://millionrounds.com/company/inbiomotion)** Series A · ES · pevc.dowjones.com **$2.5M** Sole investor
- **2011** 3 rounds
- **Dec** **[Medlumics](https://millionrounds.com/company/medlumics)** Series A · ES · finsmes.com **$4.7M** With 1 other
- **Sept** **[AM Pharma](https://millionrounds.com/company/am-pharma)** Series D · NL · am-pharma.com **$40M** With 3 others
- **Jun** **[STAT-Diagnostica](https://millionrounds.com/company/stat-diagnostica)** Series A · ES · finsmes.com **$2.8M** Sole investor
- **2010** 3 rounds
- **Sept** **[Cardoz](https://millionrounds.com/company/cardoz)** Series A · SE · finsmes.com **$18M** With 3 others
- **Sept** **[Sabirmedical](https://millionrounds.com/company/sabirmedical)** Venture · ES · finsmes.com **$6.5M** With 1 other
- **Jan** **[Cellerix](https://millionrounds.com/company/cellerix)** Series C · ES · onbiovc.com **$38M** With 5 others
- **2009** 3 rounds
- **Nov** **[Cellerix](https://millionrounds.com/company/cellerix)** Series B · ES · cellerix.com **$41M** With 5 others
- **Nov** **[BioVex](https://millionrounds.com/company/biovex)** Series F · GB · xconomy.com **$30M** With 4 others
- **Oct** **[Endosense](https://millionrounds.com/company/endosense)** Series B · CH · onbiovc.com **$36M** With 6 others
- **2007** 1 round
- **Sept** **[Cellerix](https://millionrounds.com/company/cellerix)** Series B · ES · fiercebiotech.com **$37M** With 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **12** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **2 in all**

**[Endosense](https://millionrounds.com/company/endosense)** Bought by [St. Jude Medical](https://millionrounds.com/fund/st-jude-medical) **$170M** Aug 2013

**[BioVex](https://millionrounds.com/company/biovex)** Bought by [Amgen](https://millionrounds.com/fund/amgen) **$1.0B** Jan 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A Series B

Median round joined **$33M** the round, not its cheque Alone, median **$2.8M**

Led 0 of 35 rounds **0%**

- **Said size:** $1.0M – $7.5M
- **Sole investor:** 3 rounds
- **Last cheque:** Sept 2026
- **Exits:** 2 from the portfolio

Rounds by stage said on their site

- Series B said *11*
- Series A said *8*
- Series C *7*
- Venture *2*
- Series F *2*
- Seed said *-*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Chiesi Ventures](https://millionrounds.com/fund/chiesi-ventures) 5
- [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 4
- [Idinvest Partners](https://millionrounds.com/fund/idinvest-partners) 4
- [Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) 4
- [Ventech](https://millionrounds.com/fund/ventech) 4
- [Caixa Capital Risc](https://millionrounds.com/fund/caixa-capital-risc) 3

**Pitching Ysios Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Ysios Capital. A count of rooms they were both in, not a relationship either has claimed.

[**Chiesi Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/chiesi-ventures)[**Forbion Capital Partners** Private equity **4** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**Idinvest Partners** Private equity **4** rounds together](https://millionrounds.com/fund/idinvest-partners)[**Roche Venture Fund** Corporate VC **4** rounds together](https://millionrounds.com/fund/roche-venture-fund)[**Ventech** VC firm **4** rounds together](https://millionrounds.com/fund/ventech)[**Caixa Capital Risc** VC firm **3** rounds together](https://millionrounds.com/fund/caixa-capital-risc)[**EQT life science** Private equity **3** rounds together](https://millionrounds.com/fund/lsp-bioventures)[**Gilde Healthcare** Private equity **3** rounds together](https://millionrounds.com/fund/gilde-healthcare)[**Innogest Capital** VC firm **3** rounds together](https://millionrounds.com/fund/innogest-capital)[**Novartis Venture Fund** Corporate VC **3** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Omega Funds** VC firm **3** rounds together](https://millionrounds.com/fund/omega-funds)[**Sectoral Asset Management** Private equity **3** rounds together](https://millionrounds.com/fund/sectoral-asset-management)

## Recently backed

The latest companies Ysios Capital put money into.

[**Anaconda Biomed** $56M · Sept 2026](https://millionrounds.com/company/anaconda-biomed)[**Ona Therapeutics** $87M · Jun 2026](https://millionrounds.com/company/ona-therapeutics)[**Anaconda** $22M · Dec 2019](https://millionrounds.com/company/anaconda)[**AM-Pharma** $130M · Jul 2019](https://millionrounds.com/company/am-pharma)[**Galecto** $90M · Oct 2018](https://millionrounds.com/company/galecto)[**MedLumics** $37M · Mar 2017](https://millionrounds.com/company/medlumics)

## Quick answers about Ysios Capital

### What does Ysios Capital invest in?

Ysios Capital invests most often at Series B and Series A (63% of the rounds on record), in sectors such as Banking, Funding Platform and Venture Capital & Private Equity.

### How active is Ysios Capital?

35 investments on record, 2 of them in the last 12 months. The most recent was in Sept 2026.

### What has Ysios Capital invested in recently?

Its most recent investments on record: Anaconda Biomed (Series C, Sept 2026), Ona Therapeutics (Series B, Jun 2026) and Anaconda (Series B, Dec 2019).

### How big are Ysios Capital's cheques?

The median round it joins is $33M. It says it writes cheques of $1.0M to $7.5M.

### Does Ysios Capital lead rounds?

Rarely, if at all: none of its 35 investments on record names it as the lead.

### Where does Ysios Capital invest?

Most of the companies it backs are in Spain (45%), the United States (15%) and Switzerland (15%).

### Is Ysios Capital investing now?

Yes: it is actively investing, with 2 investments in the last 12 months.

### Who does Ysios Capital invest alongside?

Most often Chiesi Ventures (5 rounds together), Forbion Capital Partners (4 rounds together) and Idinvest Partners (4 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=ysios-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=ysios-capital)